GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
Quick Stats
Jan 30, 202655.2
AI Score
HOLD0.05
Volume Ratio
Mar 13, 2026
Next Earnings
10
+ve Days (30d)
20
-ve Days (30d)
GRI Stock Summary
Last updated Jan 30, 2026
GRI is currently trading at $3.26, positioned above its 200-day moving average of $1.53, indicating a long-term uptrend. The stock has a 52-week range of $0.183 to $11.9.
Technical Analysis: The 50-day moving average stands at $1.2, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 63.954, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.155, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GRI at 55.2/100 with a HOLD recommendation.
GRI (GRI Bio, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 63.954 |
| CMF (20) | -0.155 |
| ROC (10) | 1253.821 |
| ADX (14) | 61.602 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.793 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -52.785 |
| MFI (14) | 4.33 |
GRI Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GRI Price vs Max Options Open Interest
GRI Max Change In Options Open Interest
GRI Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRI Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRI Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRI Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRI Bio, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
GRI Moving Averages Analysis
GRI Bio, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
GRI Bio, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
GRI (GRI Bio, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.26 |
| 20 | 1.26 |
| 30 | 0.95 |
| 50 | 1.2 |
| 100 | 1.54 |
| 200 | 1.53 |
GRI Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 million |
| Earnings/Share ($) | -121.8 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -48.86 |
| EPS Estimate Next Year ($) | -12.6 |
| WallStreet Target Price ($) | 643.9998 |
| Most Recent Quarter |
The stock of GRI is showing strong gains, with a 15% increase and potential for further growth to 0.35. Investors are optimistic about the potential for profit, with some suggesting it could double from its current level. The stock has had multiple attempts to break a key resistance level, indicating potential for a larger move. The recent offering price of 0.75 has also caught the attention of investors.
Updated 2025-12-30 17:00:02